4//SEC Filing
JOHNSON & JOHNSON 4
Accession 0001193125-25-296047
$JNJCIK 0001235912operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 12:54 PM ET
Size
9.1 KB
Accession
0001193125-25-296047
Insider Transaction Report
Form 4
CVRx, Inc.CVRX
JOHNSON & JOHNSON
10% Owner
Transactions
- Sale
Common Stock
2025-11-24$10.06/sh−2,200$22,132→ 4,047,198 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Sale
Common Stock
2025-11-21$10.00/sh−500$5,000→ 4,049,398 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)
Transactions
- Sale
Common Stock
2025-11-24$10.06/sh−2,200$22,132→ 4,047,198 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.) - Sale
Common Stock
2025-11-21$10.00/sh−500$5,000→ 4,049,398 total(indirect: By Johnson & Johnson Innovation - JJDC, Inc.)
Footnotes (2)
- [F1]The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
CVRx, Inc.
CIK 0001235912
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000200406
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 12:54 PM ET
- Size
- 9.1 KB